BioXcel Therapeutics Inc (BTAI)
0.5848
+0.03
(+6.31%)
USD |
NASDAQ |
Oct 04, 16:00
0.577
-0.01
(-1.33%)
After-Hours: 20:00
BioXcel Therapeutics Shareholders Equity (Annual): -56.51M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -56.51M |
| December 31, 2022 | 76.78M |
| December 31, 2021 | 221.67M |
| December 31, 2020 | 206.70M |
| Date | Value |
|---|---|
| December 31, 2019 | 26.90M |
| December 31, 2018 | 38.89M |
| December 31, 2017 | -0.982M |
| December 31, 2016 | -0.324M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
-56.51M
Minimum
2023
221.67M
Maximum
2021
95.10M
Average
76.78M
Median
2022
Shareholders Equity (Annual) Benchmarks
| Baxter International Inc | 8.402B |
| Bruker Corp | 1.377B |
| Anavex Life Sciences Corp | 141.85M |
| AdaptHealth Corp | 1.458B |
| NovaBay Pharmaceuticals Inc | 3.314M |